Silvia Garavaglia

Novara, 28100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment.

Discovery of a new selective ERAP1 inhibitor for Hedgehog-dependent cancer treatment.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 11, 2025

Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening.

Exploiting ALDH1A2 and ALDH1A3 isoform variability for crystallisation screening.

Journal: Biochemical and biophysical research communications

Published: January 26, 2025

A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors.

A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors.

Journal: Molecular diversity

Published: December 05, 2024

Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.

Toxic aldehydes in cooking vegetable oils: Generation, toxicity and disposal methods.

Journal: Food chemistry: X

Published: December 04, 2024

A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

A New Vista of Aldehyde Dehydrogenase 1A3 (ALDH1A3): New Specific Inhibitors and Activity-Based Probes Targeting ALDH1A3 Dependent Pathways in Glioblastoma, Mesothelioma and Other Cancers.

Journal: Cancers

Published: April 26, 2024

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment.

Journal: International journal of molecular sciences

Published: March 16, 2023

Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.

Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosis.

Journal: Communications biology

Published: May 27, 2021

A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.

A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In Vitro.

Journal: Cancers

Published: December 31, 2020

Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.

Imidazo[1,2-a]pyridine Derivatives as Aldehyde Dehydrogenase Inhibitors: Novel Chemotypes to Target Glioblastoma Stem Cells.

Journal: Journal of medicinal chemistry

Published: April 01, 2020

A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.

A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells.

Journal: Communications biology

Published: January 31, 2020

Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family.

Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-a]pyridines against the 1A Family.

Journal: ACS medicinal chemistry letters

Published: January 03, 2020

Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer.

Targeting NAD-dependent dehydrogenases in drug discovery against infectious diseases and cancer.

Journal: Biochemical Society transactions

Published: December 16, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026